ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,840,000 | +26.7% | 895,200 | -10.5% | 0.02% | +21.4% |
Q2 2021 | $3,030,000 | -12.3% | 1,000,000 | -3.6% | 0.01% | -12.5% |
Q1 2021 | $3,456,000 | -34.5% | 1,037,700 | -45.3% | 0.02% | -42.9% |
Q4 2019 | $5,274,000 | +278.6% | 1,897,284 | +744.5% | 0.03% | +366.7% |
Q3 2017 | $1,393,000 | – | 224,655 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
Kepos Capital LP | 200,000 | $778,000 | 0.06% |
XTX Topco Ltd | 29,026 | $113,000 | 0.06% |